The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone

Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data

(2013) Stamatina Iliodromiti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Ovarian Antral Follicle Subclasses and Anti-Müllerian Hormone During Normal Reproductive Aging

(2013) J. G. Bentzen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection

(2013) J. V. Jeppesen et al.   MOLECULAR HUMAN REPRODUCTION

Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history

(2012) Antonio La Marca et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?

(2012) T. B. Eilertsen et al.   HUMAN REPRODUCTION

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria

(2012) B. O. Yildiz et al.   HUMAN REPRODUCTION

Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception

(2012) J.G. Bentzen et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries

(2011) D. Dewailly et al.   HUMAN REPRODUCTION

Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women

(2010) Ingrid J. M. Duijkers et al.   GYNECOLOGICAL ENDOCRINOLOGY

A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?

(2010) S. L. Kristensen et al.   HUMAN REPRODUCTION

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

(2010) Lisa J. Moran et al.   HUMAN REPRODUCTION UPDATE

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women without Metabolic Significance

(2010) Erica B. Johnstone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Levels of Anti-Müllerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients

(2010) Casper P. Hagen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

(2009) W. A. March et al.   HUMAN REPRODUCTION

Anti-Mullerian hormone (AMH): what do we still need to know?

(2009) A. La Marca et al.   HUMAN REPRODUCTION

True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement

(2008) Mikkel Rosendahl et al.   FERTILITY AND STERILITY